Although other ETS family members such as ERG comprise recurrent oncogenic gene rearrangements in prostate carcinoma, we did not identify a pattern of expression of other ETS genes that could substitute for the loss of ETV1 function across LNCaP strains (Figure 4D). The gene discussed is ERG; the disease is prostate carcinoma.